Allel'nye varianty v genakh BRCA1,BRCA2, TP53, assotsiirovannyes razvitiem raka molochnoy zhelezy
Main Authors: | K V Sytenkova, Zh M Guzieva, M P Kazakov, L N Lyubchenko, I V Poddubnaya |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Habib O.N.
2011-09-01
|
Series: | Современная онкология |
Online Access: | https://modernonco.orscience.ru/1815-1434/article/view/29441 |
Similar Items
-
Kliniko-geneticheskaya geterogennost' semeynogo raka molochnoy zhelezy
by: L N Lyubchenko, et al.
Published: (2004-06-01) -
Novye vozmozhnosti endokrinnoy terapii raka molochnoy zhelezy
by: N P Makarenko, et al.
Published: (2001-09-01) -
Rol' bisfosfonatov v lechenii raka molochnoy zhelezy
by: A P Kondrat'eva, et al.
Published: (2004-06-01) -
Mesto fulvestranta v endokrinoterapiimetastaticheskogo raka molochnoy zhelezy
by: I V Kolyadina, et al.
Published: (2010-03-01) -
Everolimus: novye perspektivy terapii gormonopozitivnogo raka molochnoy zhelezy
by: I V Kolyadina, et al.
Published: (2012-12-01)